According to a recent meta-analysis, the majority of patients experienced new-onset DM1 in three months, with a median duration of diabetes with PD-1/PD-L1 inhibitors of 49 days (range: 5-448 days) [13]. The gene discussed is CD274; the disease is diabetes mellitus.